1. Home
  2. APLS vs PLUG Comparison

APLS vs PLUG Comparison

Compare APLS & PLUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLS
  • PLUG
  • Stock Information
  • Founded
  • APLS 2009
  • PLUG 1997
  • Country
  • APLS United States
  • PLUG United States
  • Employees
  • APLS N/A
  • PLUG N/A
  • Industry
  • APLS Biotechnology: Pharmaceutical Preparations
  • PLUG Industrial Machinery/Components
  • Sector
  • APLS Health Care
  • PLUG Energy
  • Exchange
  • APLS Nasdaq
  • PLUG Nasdaq
  • Market Cap
  • APLS 2.9B
  • PLUG 3.1B
  • IPO Year
  • APLS 2017
  • PLUG 1999
  • Fundamental
  • Price
  • APLS $20.39
  • PLUG $2.28
  • Analyst Decision
  • APLS Buy
  • PLUG Hold
  • Analyst Count
  • APLS 19
  • PLUG 16
  • Target Price
  • APLS $32.83
  • PLUG $2.39
  • AVG Volume (30 Days)
  • APLS 3.4M
  • PLUG 109.5M
  • Earning Date
  • APLS 10-30-2025
  • PLUG 11-10-2025
  • Dividend Yield
  • APLS N/A
  • PLUG N/A
  • EPS Growth
  • APLS N/A
  • PLUG N/A
  • EPS
  • APLS 0.36
  • PLUG N/A
  • Revenue
  • APLS $1,016,397,000.00
  • PLUG $676,169,000.00
  • Revenue This Year
  • APLS $25.39
  • PLUG $21.14
  • Revenue Next Year
  • APLS N/A
  • PLUG $25.96
  • P/E Ratio
  • APLS $56.77
  • PLUG N/A
  • Revenue Growth
  • APLS 42.11
  • PLUG 2.53
  • 52 Week Low
  • APLS $16.10
  • PLUG $0.69
  • 52 Week High
  • APLS $35.72
  • PLUG $4.58
  • Technical
  • Relative Strength Index (RSI)
  • APLS 39.49
  • PLUG 38.52
  • Support Level
  • APLS $18.93
  • PLUG $2.36
  • Resistance Level
  • APLS $30.48
  • PLUG $2.73
  • Average True Range (ATR)
  • APLS 1.29
  • PLUG 0.26
  • MACD
  • APLS -0.37
  • PLUG -0.06
  • Stochastic Oscillator
  • APLS 13.94
  • PLUG 1.30

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

About PLUG Plug Power Inc.

Plug Power is building an end-to-end green hydrogen ecosystem—from production, storage, and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets, including material handling, e-mobility, power generation, and industrial applications.

Share on Social Networks: